Gilead

Roche, Reloaded
Investopedia
Wed, 05/22/13 - 09:22 am
Roche
Gilead
Merck
Bristol-Myers Squibb
JNJ
2013 FDA Drug Approval Calendar
TheStreet.com
Tue, 05/21/13 - 12:05 pm
drug approvals
GSK
Dolutegravir
Trametenib
Auxilium
Xiaflex
Delcath
Melblez
Seattle Genetics
Adcetris
Antares
Otrexup
Amag Pharmaceuticals
Feraheme
Cubist Pharmaceuticals
Entereg
Gilead
sofosbuvir
Amarin
Vascepa
Merck
suvorexant
Valeant Pharmaceuticals
efinaconazole
Depomed
Sefelsa
Zogenix
Zohydro
dabrafenib
tivozanib
Aveo Pharmaceuticals
Will Influenza A H7N9 Generate Opportunities For Pharma?
Seeking Alpha
Tue, 05/21/13 - 10:58 am
H7N9
Flu
Gilead
GSK
Novavax
Novartis
Roche
Sanofi
Tackling Cancer: Leukemia's Biggest Current and Upcoming Players
Motley Fool
Mon, 05/20/13 - 11:40 am
leukemia
Sprycel
Bristol-Myers Squibb
Gleevec
Novartis
Iclusig
Ariad Pharmaceuticals
Bosulif
Pfizer
Erwinaze
Jazz Pharmaceuticals
Idelalisib
Gilead
ibrutinib
Pharmacyclics
ASCO '13 Preview: Gilead's Big Cancer Debut
TheStreet.com
Thu, 05/16/13 - 08:54 am
Gilead
ASCO
JNJ
Pharmacyclics
idelalisab
ibrutinib
CLL
5 Stocks Boosting The Drugs Industry Higher
TheStreet.com
Wed, 05/15/13 - 02:50 pm
Gilead
Bristol-Myers Squibb
JNJ
Merck
Pfizer
Racing Toward the Next Hepatitis C Drug Approval
Motley Fool
Wed, 05/15/13 - 09:06 am
hepatitis C
JNJ
Gilead
Merck
Roche
Vertex Pharmaceuticals
Gilead's Hepatitis C Drug Sofosbuvir Offers Upside
Seeking Alpha
Thu, 05/9/13 - 09:40 am
hepatitis C
sofosbuvir
Gilead
Leading Biotechs Act Well But Be Careful Not To Chase
Investors.com
Tue, 05/7/13 - 11:39 am
Biogen Idec
Regeneron
Amgen
Celgene
Gilead
Gilead's HCV Drug Pipeline Outshines Weak Q1 Results
Investors.com
Fri, 05/3/13 - 08:54 am
earnings
Gilead
hepatitis C
Gilead combo hepatitis C pill shown effective in small trial
Reuters
Thu, 05/2/13 - 10:28 am
hepatitis C
Gilead
ledipasvir
sofosbuvir
Gilead Sciences Earnings Preview: Get Ahead of the Analysts
Wall St. Cheat Sheet
Thu, 05/2/13 - 10:27 am
earnings
Gilead
FDA rejects two Gilead HIV drugs as standalone products
Reuters
Mon, 04/29/13 - 10:49 am
FDA
HIV
Gilead
cobicistat
elvitegravir
Stribild
Gilead-Bristol Hepatitis C Drug Combo Cures All in Study
Bloomberg
Mon, 04/29/13 - 10:26 am
Gilead
Bristol-Myers Squibb
hepatitis C
declatasvir
sofosbuvir
5 Top Biotechs With Bolting Stocks, Earnings On Tap
Investors.com
Tue, 04/23/13 - 11:34 am
earnings
Medicines Company
Celgene
Gilead
Amgen
Biogen Idec
Bristol Still Playing Catch-Up To Gilead In Hep C Drug Race
TheStreet.com
Tue, 04/23/13 - 11:21 am
Gilead
Bristol-Myers Squibb
hepatitis C
sofosbuvir
daclatasvir
asunaprevir
BMS-791325
Gilead announces results from Phase 3 trial evaluating sofosbuvir
Yahoo/Fly on the Wall
Tue, 04/23/13 - 11:06 am
Gilead
hepatitis C
sofosbuvir
Whisper Number Impact: Earnings Preview For Gilead Sciences
Seeking Alpha
Mon, 04/22/13 - 02:07 pm
Gilead
earnings
Worth Repeating: Vertex Is The Next Gilead Sciences
TheStreet.com
Fri, 04/19/13 - 08:54 am
Gilead
Vertex Pharmaceuticals
Kalydeco
VX-661
These 4 'High-Potential' Biotech Stocks Could Outperform In 2013
Seeking Alpha
Thu, 04/18/13 - 06:57 pm
Arena Pharmaceuticals
Gilead
Biomarin
Acadia
Catalyst Pharmaceutical Partners

Pages